Inventor · disambiguated record
Matthias Dreyer
Also filed as: DREYER MATTHIAS
4 granted patents·12 pending applications·2 citations·filing 2007–2024
60Inventor score
Top patents by PatentIndex Score
16 records- 0183US11230582B2FGF21 variantsSANOFI SA·Filed 2016·Granted Jan 25, 2022·2 cites·6 claims
- 0277US2025171512A1Fgf21 variantsSANOFI SA·Filed 2024·Application pending·0 cites
- 0371US2025115669A1FGFR1/KLB Targeting Agonistic Antigen-Binding Proteins and Conjugates Thereof with GLP-1R Agonistic PeptidesSANOFI SA·Filed 2024·Application pending·0 cites
- 0466US2022227825A1Fgf21 variantsSANOFI SA·Filed 2021·Application pending·0 cites
- 0561US12054551B2FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptidesSANOFI SA·Filed 2021·Granted Aug 6, 2024·0 cites·14 claims
- 0656US2018236033A1Pharmaceutical composition for treating a metabolic syndromeSANOFI SA·Filed 2018·Application pending·0 cites
- 0755US8501736B2Isoquinoline derivativesPLETTENBURG OLIVER·Filed 2007·Granted Aug 6, 2013·0 cites·42 claims
- 0853US2019085043A1Fusion proteins for treating a metabolic syndromeSANOFI SA·Filed 2018·Application pending·0 cites
- 0951US2014073563A1Fusion proteins for treating a metabolic syndromeBOSCHEINEN OLIVER·Filed 2013·Application pending·0 cites
- 1050US2016279199A1Pharmaceutical composition for treating a metabolic syndromeSANOFI SA·Filed 2016·Application pending·0 cites
- 1149US2013203651A1Pharmaceutical composition for treating a metabolic syndromeSOMMERFELD MARK·Filed 2011·Application pending·0 cites
- 1247US2015231210A1Pharmaceutical Composition for Treating a Metabolic SyndromeSANOFI SA·Filed 2015·Application pending·0 cites
- 1346US8722671B2Isoquinoline derivativesPLETTENBURG OLIVER·Filed 2011·Granted May 13, 2014·0 cites·25 claims
- 1446US2016194371A1Fusion proteins comprising FGF-21 and GLP-1R agonistSANOFI SA·Filed 2015·Application pending·0 cites
- 1537US2014142023A1Pharmaceutical Composition for Treating A Metabolic SyndromeSOMMERFELD MARK·Filed 2012·Application pending·0 cites
- 1636US2021170033A1Novel conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing proteinSANOFI SA·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →